Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Schennach

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
The International Journal of Neuropsychopharmacology|September 19, 2013
History, background, concepts and current use of comedication and polypharmacy in psychiatryH-J Möller, F Seemüller, R Schennach-Wolff, et al.
Ophthalmology and Therapy|December 9, 2022
Micro-Computed Tomography (µCT) as a Tool for High-Resolution 3D Imaging and Analysis of Intraocular Lenses: Feasibility and Proof of the Methodology to Evaluate YAG PitsA F Borkenstein, E M Borkenstein, E Machado, et al.
Der Nervenarzt|April 2, 2010
[Bipolar depression. Spectrum of clinical pictures and differentiation from unipolar depression]F Seemüller, M Riedel, S Dargel, et al.
Pharmacopsychiatry|May 23, 2012
The relationship of Akathisia with treatment emergent suicidality among patients with first-episode schizophrenia treated with haloperidol or risperidoneF Seemüller, U Lewitzka, M Bauer, et al.
Human Psychopharmacology|March 3, 2010
Neurocognition and its influencing factors in the treatment of schizophrenia-effects of aripiprazole, olanzapine, quetiapine and risperidoneM Riedel, R Schennach-Wolff, R Musil, et al.
Pharmacopsychiatry|March 26, 2010
Effect of aripiprazole on cognition in the treatment of patients with schizophreniaM Riedel, I Spellmann, R Schennach-Wolff, et al.
Acta Psychiatrica Scandinavica|September 11, 2012
Should early improvement be re-defined to better predict the maintenance of response in first-episode schizophrenia patients?R Schennach, M Riesbeck, A Mayr, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|March 12, 2011
The validity of self-rated psychotic symptoms in depressed inpatientsF Seemüller, M Riedel, M Obermeier, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|May 1, 2012
Insight in schizophrenia-course and predictors during the acute treatment phase of patients suffering from a schizophrenia spectrum disorderR Schennach, S Meyer, F Seemüller, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|December 27, 2014
What are depressive symptoms in acutely ill patients with schizophrenia spectrum disorder?R Schennach, M Riedel, M Obermeier, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
The International Journal of Neuropsychopharmacology|September 19, 2013
History, background, concepts and current use of comedication and polypharmacy in psychiatryH-J Möller, F Seemüller, R Schennach-Wolff, et al.
Ophthalmology and Therapy|December 9, 2022
Micro-Computed Tomography (µCT) as a Tool for High-Resolution 3D Imaging and Analysis of Intraocular Lenses: Feasibility and Proof of the Methodology to Evaluate YAG PitsA F Borkenstein, E M Borkenstein, E Machado, et al.
Der Nervenarzt|April 2, 2010
[Bipolar depression. Spectrum of clinical pictures and differentiation from unipolar depression]F Seemüller, M Riedel, S Dargel, et al.
Pharmacopsychiatry|May 23, 2012
The relationship of Akathisia with treatment emergent suicidality among patients with first-episode schizophrenia treated with haloperidol or risperidoneF Seemüller, U Lewitzka, M Bauer, et al.
Human Psychopharmacology|March 3, 2010
Neurocognition and its influencing factors in the treatment of schizophrenia-effects of aripiprazole, olanzapine, quetiapine and risperidoneM Riedel, R Schennach-Wolff, R Musil, et al.
Pharmacopsychiatry|March 26, 2010
Effect of aripiprazole on cognition in the treatment of patients with schizophreniaM Riedel, I Spellmann, R Schennach-Wolff, et al.
Acta Psychiatrica Scandinavica|September 11, 2012
Should early improvement be re-defined to better predict the maintenance of response in first-episode schizophrenia patients?R Schennach, M Riesbeck, A Mayr, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|March 12, 2011
The validity of self-rated psychotic symptoms in depressed inpatientsF Seemüller, M Riedel, M Obermeier, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|May 1, 2012
Insight in schizophrenia-course and predictors during the acute treatment phase of patients suffering from a schizophrenia spectrum disorderR Schennach, S Meyer, F Seemüller, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|December 27, 2014
What are depressive symptoms in acutely ill patients with schizophrenia spectrum disorder?R Schennach, M Riedel, M Obermeier, et al.
Pageof 3